#Health / Well-being #Therapeutics
- Tyrosine kinase inhibitors
- Amyotrophic lateral sclerosis
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#Health / Well-being #Therapeutics
Research, development and commercialization of tyrosine kinase inhibitors as targeted therapy for pathologies with unmet medical needs.
AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discovering key mechanisms in life science and developing new drugs targeting these mechanisms to dramatically change the lives of patients in the most unmet medical needs. Since May 2016, the company has a R&D laboratory located at Genopole in Évry.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
AB Science is specialized in the development of highly specific tyrosine kinase inhibitors to treat pathologies with unmet medical needs in the fields of cancer, neurodegenerative disorders and chronic inflammatory diseases. Masitinib, the company’s key compound, is commercialized in veterinary medicine and is approaching commercialization in human medicine. Masitinib displayed off-target immunomodulating properties that the Genopole laboratory studies at a preclinical stage.
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
The clinical development of Masitinib for human use is very advanced with 13 phase III trials in progress. Two applications for marketing authorization, one in mastocytosis and the other in amyotrophic lateral sclerosis, were submitted for this product to EMA in 2016.
#Health / Well-being
Biotechnology, R&D, Drug development, oncology, obesity, infectious diseasesDiscover
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.Discover
Artificial intelligence to optimize and accelerate the development of gene therapiesDiscover
Production of BCG vaccines and BCG-based cancer and inflammation treatments, preparation and distribution of fresh log-phase BCG cultures.Discover
Software for biomedical data analysisDiscover
Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).Discover
Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.Discover
Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.Discover
Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).Discover
PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.Discover
LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.Discover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.Discover
Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.Discover
Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.Discover
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.Discover
Research and valorization of microalgae for cosmetic, nutraceutic and therapeutic applications.Discover
AiiNTENSE provides a complete cognitive assistance solution to improve the medical, ethical and economic management of patients in intensive care units.Discover
Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.Discover
AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.Discover